Literature DB >> 11181338

Bacteriophage therapy.

A Sulakvelidze1, Z Alavidze, J G Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181338      PMCID： PMC90351          DOI： 10.1128/AAC.45.3.649-659.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  54 in total

1.  Studies on bacteriophage penetration in patients subjected to phage therapy.

Authors:  B Weber-Dabrowska; M Dabrowski; S Slopek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

2.  [Use of bacteriophages in the treatment of chronic bacterial diseases].

Authors:  H Kaczkowski; B Weber-Dabrowska; M Dabrowski; Z Zdrojewicz; F Cwioro
Journal:  Wiad Lek       Date:  1990 Feb 1-15

3.  High abundance of viruses found in aquatic environments.

Authors:  O Bergh; K Y Børsheim; G Bratbak; M Heldal
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

4.  [Bacteriophages and their therapeutic-prophylactic use].

Authors:  A B Chernomordik
Journal:  Med Sestra       Date:  1989-06

5.  [Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms].

Authors:  V A Kochetkova; A S Mamontov; R L Moskovtseva; E I Erastova; E I Trofimov; M I Popov; S K Dzhubalieva
Journal:  Sov Med       Date:  1989

6.  Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.

Authors:  S Slopek; B Weber-Dabrowska; M Dabrowski; A Kucharewicz-Krukowska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

7.  Immunogenic effect of bacteriophage in patients subjected to phage therapy.

Authors:  A Kucharewicz-Krukowska; S Slopek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

8.  Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.

Authors:  S Slopek; A Kucharewicz-Krukowska; B Weber-Dabrowska; M Dabrowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1985       Impact factor: 4.291

9.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05

10.  Bacteriophage treatment of suppurative skin infections.

Authors:  M Cisło; M Dabrowski; B Weber-Dabrowska; A Woytoń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291
View more
  407 in total

1.  Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

Authors:  Alex R Hall; Daniel De Vos; Ville-Petri Friman; Jean-Paul Pirnay; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

Authors:  Caroline Westwater; Laura M Kasman; David A Schofield; Phillip A Werner; Joseph W Dolan; Michael G Schmidt; James S Norris
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 3.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Phage-host interaction: an ecological perspective.

Authors:  Sandra Chibani-Chennoufi; Anne Bruttin; Marie-Lise Dillmann; Harald Brüssow
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

5.  Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain.

Authors:  S B Santos; E Fernandes; C M Carvalho; S Sillankorva; V N Krylov; E A Pleteneva; O V Shaburova; A Nicolau; E C Ferreira; J Azeredo
Journal:  Appl Environ Microbiol       Date:  2010-09-03       Impact factor: 4.792

Review 6.  Bacteriophage resistance mechanisms.

Authors:  Simon J Labrie; Julie E Samson; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

7.  The phage therapy paradigm: prêt-à-porter or sur-mesure?

Authors:  Jean-Paul Pirnay; Daniel De Vos; Gilbert Verbeken; Maia Merabishvili; Nina Chanishvili; Mario Vaneechoutte; Martin Zizi; Geert Laire; Rob Lavigne; Isabelle Huys; Guy Van den Mooter; Angus Buckling; Laurent Debarbieux; Flavie Pouillot; Joana Azeredo; Elisabeth Kutter; Alain Dublanchet; Andrzej Górski; Revaz Adamia
Journal:  Pharm Res       Date:  2010-11-10       Impact factor: 4.200

8.  Metabolic responses to Lactobacillus plantarum contamination or bacteriophage treatment in Saccharomyces cerevisiae using a GC-MS-based metabolomics approach.

Authors:  Feng-Xia Cui; Rui-Min Zhang; Hua-Qing Liu; Yan-Feng Wang; Hao Li
Journal:  World J Microbiol Biotechnol       Date:  2015-09-18       Impact factor: 3.312

9.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

10.  Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.

Authors:  Sandra Chibani-Chennoufi; Josette Sidoti; Anne Bruttin; Marie-Lise Dillmann; Elizabeth Kutter; Firdausi Qadri; Shafiqul Alam Sarker; Harald Brüssow
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.